Literature DB >> 15452253

Transient immunosuppression stops rejection of virus-transduced enhanced green fluorescent protein in rabbit retina.

Kentaro Doi1, Jian Kong, Janos Hargitai, Stephen P Goff, Peter Gouras.   

Abstract

The expression of lentivirus-transduced enhanced green fluorescent protein (EGFP) was detectable in rabbit retinal pigment epithelium (RPE) within 3 to 5 days after subretinal injection of the vector. Within 2 to 3 weeks, EGFP-expressing cells were eliminated by rejection. In the current experiments, we monitor serum antibody titers for EGFP before and after transduction and determine whether systemic immunosuppression prevents recognition of EGFP by the immune system. While all control rabbits developed antibodies against EFGP and showed signs of rejection, no such evidence was observed with animals which received immunosuppression. One month of systemic immunosuppression permanently prevented rejection of RPE with EGFP expression. Fluorescence has been maintained for more than a year. If a control eye was injected with the same virus after terminating immunosuppression, both eyes showed signs of rejection. The lack of rejection is not due to tolerance but to a failure of the animals to detect the foreign protein. Detection must depend upon a brief window of time after surgery needed to introduce the vector, perhaps related to a concurrent but transient inflammation. This strategy may be useful in managing other types of rejection in the retina.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452253      PMCID: PMC521797          DOI: 10.1128/JVI.78.20.11327-11333.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Lentiviral transduction of green fluorescent protein in retinal epithelium: evidence of rejection.

Authors:  K Doi; J Hargitai; J Kong; S H Tsang; M Wheatley; S Chang; S Goff; P Gouras
Journal:  Vision Res       Date:  2002-02       Impact factor: 1.886

2.  CD45-positive cells of the retina and their responsiveness to in vivo and in vitro treatment with IFN-gamma or anti-CD40.

Authors:  Dale S Gregerson; Jing Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-07       Impact factor: 4.799

3.  Immune response to green fluorescent protein: implications for gene therapy.

Authors:  R Stripecke; M Carmen Villacres; D Skelton; N Satake; S Halene; D Kohn
Journal:  Gene Ther       Date:  1999-07       Impact factor: 5.250

4.  Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis.

Authors:  B Serafini; S Columba-Cabezas; F Di Rosa; F Aloisi
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

5.  Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD.

Authors:  P V Algvere; P Gouras; E Dafgård Kopp
Journal:  Eur J Ophthalmol       Date:  1999 Jul-Sep       Impact factor: 2.597

6.  Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors.

Authors:  Andrew J Lotery; Todd A Derksen; Stephen R Russell; Robert F Mullins; Sybille Sauter; Louisa M Affatigato; Edwin M Stone; Beverly L Davidson
Journal:  Hum Gene Ther       Date:  2002-04-10       Impact factor: 5.695

7.  Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope.

Authors:  A Gambotto; G Dworacki; V Cicinnati; T Kenniston; J Steitz; T Tüting; P D Robbins; A B DeLeo
Journal:  Gene Ther       Date:  2000-12       Impact factor: 5.250

8.  Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection.

Authors:  Todd A Derksen; Sybille L Sauter; Beverly L Davidson
Journal:  J Gene Med       Date:  2002 Sep-Oct       Impact factor: 4.565

9.  Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.

Authors:  A Auricchio; G Kobinger; V Anand; M Hildinger; E O'Connor; A M Maguire; J M Wilson; J Bennett
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

10.  Delivery of adeno-associated virus vectors to the fetal retina: impact of viral capsid proteins on retinal neuronal progenitor transduction.

Authors:  Enrico M Surace; Alberto Auricchio; Samuel J Reich; Tonia Rex; Ernest Glover; Stacey Pineles; Waixing Tang; Erin O'Connor; Arkady Lyubarsky; Andrey Savchenko; Edward N Pugh; Albert M Maguire; James M Wilson; Jean Bennett
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  5 in total

Review 1.  A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space.

Authors:  Sara Royce Hynes; Erin B Lavik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-19       Impact factor: 3.117

Review 2.  Strategies to modulate immune responses: a new frontier for gene therapy.

Authors:  Valder R Arruda; Patricia Favaro; Jonathan D Finn
Journal:  Mol Ther       Date:  2009-07-07       Impact factor: 11.454

3.  Knockdown of NBCe1 in vivo compromises the corneal endothelial pump.

Authors:  Cailing Liu; Qiang Cheng; Tracy Nguyen; Joseph A Bonanno
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-05       Impact factor: 4.799

Review 4.  Gene therapy targeting glaucoma: where are we?

Authors:  Xuyang Liu; Carol A Rasmussen; B'ann T Gabelt; Curtis R Brandt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

5.  Peripapillary Intravitreal Injection Improves AAV-Mediated Retinal Transduction.

Authors:  Sanjar Batirovich Madrakhimov; Jin Young Yang; Dong Hyuck Ahn; Jung Woo Han; Tae Ho Ha; Tae Kwann Park
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-30       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.